To review the regenerative benefits and mechanisms of stem cell-based therapies for female infertility.
Approach:
Types of Stem Cells: The review discusses various stem cell types including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), and ovarian/endometrial progenitor cells, focusing on their mechanisms and clinical applications.
Key Findings:
MSCs are the most researched stem cell type for infertility, showing significant therapeutic effects through paracrine signaling.
iPSCs can differentiate into germ-cell-like cells and have potential for artificial gametogenesis, but face challenges such as tumorigenicity.
ESCs raise ethical concerns due to their potential to form teratomas and difficulties in achieving specific differentiation.
Interpretation:
While stem cell therapies show promise in addressing female infertility, issues related to standardization, safety, and ethics remain.
Limitations:
Current research is limited by the need for standardized protocols and clinical validation.
Ethical concerns surrounding the use of ESCs and the potential risks associated with iPSCs.
Conclusion:
Further technological development and carefully designed clinical trials are essential for successful translation of stem cell therapies in female infertility.
